AMSTERDAM, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Polpharma Group, one of the largest pharmaceutical groups operating across Central and Eastern Europe and Central Asia, announces a planned leadership transition. Effective January 1, 2026, Markus Sieger will step down as CEO of the Group , after a decade of dedicated service. He will continue to support the strategic development of the Group as a member of the Supervisory Board, in line with the succession plan agreed upon at the start of his tenure. Under Mark ...